In the BioHarmony Drug Report Database

"Preview" Icon

Parathyroid hormone

Natpara, Natpar (parathyroid hormone) is a protein pharmaceutical. Parathyroid hormone was first approved as Natpara on 2015-01-23. It is used to treat hypocalcemia and hypoparathyroidism in the USA. It has been approved in Europe to treat hypoparathyroidism. It is known to target prolactin-releasing peptide receptor, parathyroid hormone 2 receptor, and parathyroid hormone/parathyroid hormone-related peptide receptor.

 

Trade Name

 

Natpar
 

Common Name

 

parathyroid hormone
 

ChEMBL ID

 

CHEMBL2108078
 

Indication

 

hypocalcemia, hypoparathyroidism
 

Drug Class

 

Image (chem structure or protein)

Parathyroid hormone structure rendering